AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
THE EFFECTIVENESS OF SCREENING ON ORAL OR ENT INFECTION SOURCES IN BREAST-CANCER PATIENTS PRIOR TO PERIPHERAL STEM-CELL TRANSPLANTATION
Authors: VANDERGRAAF WTA ROODENBURG JLN VANDERLAAN BFAM OOSTERHUIS BE SIELING GCM DEVRIES EGE MULDER NH WILLEMSE PHB TENVERGERT EM SLEIJFER DT
Citation: Wta. Vandergraaf et al., THE EFFECTIVENESS OF SCREENING ON ORAL OR ENT INFECTION SOURCES IN BREAST-CANCER PATIENTS PRIOR TO PERIPHERAL STEM-CELL TRANSPLANTATION, Annals of oncology, 9, 1998, pp. 135-135
EFFECTS OF PERIPHERAL STEM-CELL OR BONE-MARROW TRANSPLANTATION ON PERIPHERAL SEROTONIN METABOLISM
Authors: WYMENGA ANW VANDERGRAAF WTA KEMA IP DEVRIES EGE HOSPERS GAP MULDER NH
Citation: Anw. Wymenga et al., EFFECTS OF PERIPHERAL STEM-CELL OR BONE-MARROW TRANSPLANTATION ON PERIPHERAL SEROTONIN METABOLISM, Annals of oncology, 9, 1998, pp. 626-626
RISK OF ENDOMETRIAL CANCER IN PREMENOPAUSAL WOMEN ON TAMOXIFEN
Authors: GIETEMA JA MEINARDI MT VANDERGRAAF WTA UGES DRA SLEIJFER DT
Citation: Ja. Gietema et al., RISK OF ENDOMETRIAL CANCER IN PREMENOPAUSAL WOMEN ON TAMOXIFEN, Lancet, 352(9138), 1998, pp. 1476-1476
MALIGNANT FIBROUS HISTIOCYTOMA OF BONE - A CLINICOPATHOLOGICAL STUDY OF 81 PATIENTS
Authors: HOEKSTRA HJ HAM SJ VANDERGRAAF WTA KAMPS WA MOLENAAR WM KOOPS HS
Citation: Hj. Hoekstra et al., MALIGNANT FIBROUS HISTIOCYTOMA OF BONE - A CLINICOPATHOLOGICAL STUDY OF 81 PATIENTS, Cancer, 82(5), 1998, pp. 993-994
COMPLETE IN-VIVO REVERSAL OF P-GLYCOPROTEIN PUMP FUNCTION IN THE BLOOD-BRAIN-BARRIER VISUALIZED WITH POSITRON-EMISSION-TOMOGRAPHY
Authors: HENDRIKSE NH SCHINKEL AH DEVRIES EGE FLUKS E VANDERGRAAF WTA WILLEMSEN ATM VAALBURG W FRANSSEN EJF
Citation: Nh. Hendrikse et al., COMPLETE IN-VIVO REVERSAL OF P-GLYCOPROTEIN PUMP FUNCTION IN THE BLOOD-BRAIN-BARRIER VISUALIZED WITH POSITRON-EMISSION-TOMOGRAPHY, British Journal of Pharmacology, 124(7), 1998, pp. 1413-1418
TC-99M-SESTAMIBI IS A SUBSTRATE FOR P-GLYCOPROTEIN AND THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN
Authors: HENDRIKSE NH FRANSSEN EJF VANDERGRAAF WTA MEIJER C PIERS DA VAALBURG W DEVRIES EGE
Citation: Nh. Hendrikse et al., TC-99M-SESTAMIBI IS A SUBSTRATE FOR P-GLYCOPROTEIN AND THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN, British Journal of Cancer, 77(3), 1998, pp. 353-358
A PHASE-II STUDY OF PRIMARY INTRAPERITONEAL PACLITAXEL COMBINED WITH CBDCA CYTOXAN (CC) IN PRIMARY OC/
Authors: WILLEMSE PHB HOFSTRA L BEIJNEN JH DEVRIES EGE VANDERZEE AGJ VANDERGRAAF WTA BOONSTRA H SLEIJFER DT PIERS DA MULDER NH
Citation: Phb. Willemse et al., A PHASE-II STUDY OF PRIMARY INTRAPERITONEAL PACLITAXEL COMBINED WITH CBDCA CYTOXAN (CC) IN PRIMARY OC/, European journal of cancer, 33, 1997, pp. 534-534
ATAXIA FOLLOWING DOCETAXEL INFUSION
Authors: HOFSTRA LS VANDERGRAAF WTA DEVRIES EGE HAAXMAREICHE H WILLEMSE PHB
Citation: Ls. Hofstra et al., ATAXIA FOLLOWING DOCETAXEL INFUSION, Annals of oncology, 8(8), 1997, pp. 812-813
PULMONARY-FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND RADIOTHERAPY IN PATIENTS WITH ADVANCED LOCO-REGIONAL BREAST-CANCER
Authors: DOLSMA WV DEVRIES EGE VANDERMARK TW SLEIJFER DT WILLEMSE PHB VANDERGRAAF WTA MULDER POM SZABO BG MULDER NH
Citation: Wv. Dolsma et al., PULMONARY-FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND RADIOTHERAPY IN PATIENTS WITH ADVANCED LOCO-REGIONAL BREAST-CANCER, Anticancer research, 17(1B), 1997, pp. 537-540
A NEW IN-VITRO ASSAY FOR QUANTITATION OF CHEMOTHERAPY-INDUCED MUCOSITIS
Authors: WYMENGA ANM VANDERGRAAF WTA SPIJKERVET FLK TIMENS W TIMMERBOSSCHA H SLUITER WJ DEVRIES EGE MULDER NH
Citation: Anm. Wymenga et al., A NEW IN-VITRO ASSAY FOR QUANTITATION OF CHEMOTHERAPY-INDUCED MUCOSITIS, British Journal of Cancer, 76(8), 1997, pp. 1062-1066
CARDIOTOXICITY FROM INTENSIVE CHEMOTHERAPY COMBINED WITH RADIOTHERAPYIN BREAST-CANCER
Authors: DEGRAAF H DOLSMA WV WILLEMSE PHB VANDERGRAAF WTA SLEIJFER DT DEVRIES EGE MULDER NH
Citation: H. Degraaf et al., CARDIOTOXICITY FROM INTENSIVE CHEMOTHERAPY COMBINED WITH RADIOTHERAPYIN BREAST-CANCER, British Journal of Cancer, 76(7), 1997, pp. 943-945
PACLITAXEL, IFOSFAMIDE AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR OR RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER - A FEASIBILITY STUDY
Authors: VELDHUIS GJ WILLEMSE PHB BEIJNEN JH BOONSTRA H PIERSMA H VANDERGRAAF WTA DEVRIES EGE
Citation: Gj. Veldhuis et al., PACLITAXEL, IFOSFAMIDE AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR OR RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER - A FEASIBILITY STUDY, British Journal of Cancer, 75(5), 1997, pp. 703-709
RANDOMIZED COMPARISON OF ETOPOSIDE PHARMACOKINETICS AFTER ORAL ETOPOSIDE PHOSPHATE AND ORAL ETOPOSIDE
Authors: DEJONG RS MULDER NH UGES DRA KAUL S WINOGRAD B SLEIJFER DT GROEN HJM WILLEMSE PHB VANDERGRAAF WTA DEVRIES EGE
Citation: Rs. Dejong et al., RANDOMIZED COMPARISON OF ETOPOSIDE PHARMACOKINETICS AFTER ORAL ETOPOSIDE PHOSPHATE AND ORAL ETOPOSIDE, British Journal of Cancer, 75(11), 1997, pp. 1660-1666
A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY COMPARING DAILY 2-MG AND 5-MG OF TROPISETRON FOR THE CONTROL OF NAUSEA AND VOMITING INDUCED BY LOW-DOSE CISPLATIN-CONTAINING OR NON-CISPLATIN-CONTAINING CHEMOTHERAPY
Authors: WYMENGA ANM VANDERGRAAF WTA WILS JA VANHEUKELOM LS VANDERLINDEN GHM DULLEMONDWESTLAND AC NOOY M VANDERHEUL C DEBRUIJN KM DEVRIES EGE
Citation: Anm. Wymenga et al., A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY COMPARING DAILY 2-MG AND 5-MG OF TROPISETRON FOR THE CONTROL OF NAUSEA AND VOMITING INDUCED BY LOW-DOSE CISPLATIN-CONTAINING OR NON-CISPLATIN-CONTAINING CHEMOTHERAPY, Annals of oncology, 7(5), 1996, pp. 505-510
THE VALUE OF HIGH-DOSE METHOTREXATE-BASED NEOADJUVANT CHEMOTHERAPY INMALIGNANT FIBROUS HISTIOCYTOMA OF BONE
Authors: HAM SJ HOEKSTRA HJ VANDERGRAAF WTA KAMPS WA MOLENAAR WM KOOPS HS
Citation: Sj. Ham et al., THE VALUE OF HIGH-DOSE METHOTREXATE-BASED NEOADJUVANT CHEMOTHERAPY INMALIGNANT FIBROUS HISTIOCYTOMA OF BONE, Journal of clinical oncology, 14(2), 1996, pp. 490-496
COMPLICATIONS OF VENOUS ACCESS PORTS IN 132 PATIENTS WITH DISSEMINATED TESTICULAR CANCER TREATED WITH POLYCHEMOTHERAPY
Authors: LEMMERS NWM GELS ME SLEIJFER DT PLUKKER JT VANDERGRAAF WTA DELANGEN ZJ DROSTE JHJ KOOPS HS HOEKSTRA HJ
Citation: Nwm. Lemmers et al., COMPLICATIONS OF VENOUS ACCESS PORTS IN 132 PATIENTS WITH DISSEMINATED TESTICULAR CANCER TREATED WITH POLYCHEMOTHERAPY, Journal of clinical oncology, 14(11), 1996, pp. 2916-2922
SUCCESSFUL TREATMENT ON AN OUTPATIENT BASIS OF A PATIENT WITH DOWNS-SYNDROME AND DISSEMINATED TESTICULAR SEMINOMA
Authors: SLEIJFER S KOOPS HS VANDERGRAAF WTA
Citation: S. Sleijfer et al., SUCCESSFUL TREATMENT ON AN OUTPATIENT BASIS OF A PATIENT WITH DOWNS-SYNDROME AND DISSEMINATED TESTICULAR SEMINOMA, Netherlands journal of medicine, 48(3), 1996, pp. 89-91
CARBON-11-LABELED DAUNORUBICIN AND VERAPAMIL FOR PROBING P-GLYCOPROTEIN IN TUMORS WITH PET
Authors: ELSINGA PH FRANSSEN EJF HENDRIKSE NH FLUKS L WEEMAES AMA VANDERGRAAF WTA DEVRIES GE VISSER GM VAALBURG W
Citation: Ph. Elsinga et al., CARBON-11-LABELED DAUNORUBICIN AND VERAPAMIL FOR PROBING P-GLYCOPROTEIN IN TUMORS WITH PET, The Journal of nuclear medicine, 37(9), 1996, pp. 1571-1575
DETERMINATION OF FUNCTIONAL P-GLYCOPROTEIN IN PATIENTS WITH SOLID TUMORS BY TECHNETIUM-99M-SESTAMIBI SCINTIGRAPHY WITH AND WITHOUT PSC-833
Authors: FRANSSEN EJF KOOL W BAKKER M VANDERGRAAF WTA HOLLEMA H GROEN HJM MULLER E SMIT EF DEVRIES EGE PIERS DA
Citation: Ejf. Franssen et al., DETERMINATION OF FUNCTIONAL P-GLYCOPROTEIN IN PATIENTS WITH SOLID TUMORS BY TECHNETIUM-99M-SESTAMIBI SCINTIGRAPHY WITH AND WITHOUT PSC-833, The Journal of nuclear medicine, 37(5), 1996, pp. 257-257
TC-SESTAMIBI IS TRANSPORTED BY P-GLYCOPROTEIN AND THE MULTIDRUG-RESISTANCE ASSOCIATED PROTEIN
Authors: HENDRIKSE NH DEVRIES EGE VANDERGRAAF WTA MEIJER C PIERS DA VAALBURG W FRANSSEN EJF
Citation: Nh. Hendrikse et al., TC-SESTAMIBI IS TRANSPORTED BY P-GLYCOPROTEIN AND THE MULTIDRUG-RESISTANCE ASSOCIATED PROTEIN, The Journal of nuclear medicine, 37(10), 1996, pp. 1828-1828
P-GLYCOPROTEIN MONITORING OF C-11 DAUNORUBICIN AND VERAPAMIL IN P-GLYCOPROTEIN GENE KNOCK-OUT AND WILD-TYPE MICE WITH PET
Authors: FRANSSEN EJF HENDRIKSE NH ELSINGA PH FLUKS E SCHINKEL AH VANDERGRAAF WTA VANLOENENWEEMAES AMA DEVRIES EGE VAALBURG W
Citation: Ejf. Franssen et al., P-GLYCOPROTEIN MONITORING OF C-11 DAUNORUBICIN AND VERAPAMIL IN P-GLYCOPROTEIN GENE KNOCK-OUT AND WILD-TYPE MICE WITH PET, The Journal of nuclear medicine, 37(10), 1996, pp. 1838-1838
TREATMENT OF ADVANCED SEMINOMA WITH CYCLOPHOSPHAMIDE, VINCRISTINE ANDCARBOPLATIN ON AN OUTPATIENT BASIS
Authors: SLEIJFER S WILLEMSE PHB DEVRIES EGE VANDERGRAAF WTA KOOPS HS MULDER NH
Citation: S. Sleijfer et al., TREATMENT OF ADVANCED SEMINOMA WITH CYCLOPHOSPHAMIDE, VINCRISTINE ANDCARBOPLATIN ON AN OUTPATIENT BASIS, British Journal of Cancer, 74(6), 1996, pp. 947-950
DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-BETA IN P-GP AND MRP-NEGATIVE VM26, MAMSA AND MITOXANTRONE-RESISTANT SUBLINES OF THE HUMAN SCLC CELL-LINE GLC(4)
Authors: WITHOFF S DEVRIES EGE KEITH WN NIENHUIS EF VANDERGRAAF WTA UGES DRA MULDER NH
Citation: S. Withoff et al., DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-BETA IN P-GP AND MRP-NEGATIVE VM26, MAMSA AND MITOXANTRONE-RESISTANT SUBLINES OF THE HUMAN SCLC CELL-LINE GLC(4), British Journal of Cancer, 74(12), 1996, pp. 1869-1876
HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL REINFUSION AND GROWTH-FACTOR SUPPORT FOR SOLID TUMORS
Authors: DEVRIES EGE DEGRAAF H BOONSTRA A VANDERGRAAF WTA MULDER NH
Citation: Ege. Devries et al., HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL REINFUSION AND GROWTH-FACTOR SUPPORT FOR SOLID TUMORS, Stem cells, 13(6), 1995, pp. 597-606
ELEVATION OF SERUM HUMAN CHORIONIC-GONADOTROPIN AS THE ONLY INDICATION FOR ISOLATED CEREBRAL RELAPSE OF A GERM-CELL TUMOR OF THE TESTIS
Authors: VANDERGRAAF WTA MULDER NH MOOIJ JJA KOOPS HS HEESTERS MAAM SLEIJFER DT
Citation: Wta. Vandergraaf et al., ELEVATION OF SERUM HUMAN CHORIONIC-GONADOTROPIN AS THE ONLY INDICATION FOR ISOLATED CEREBRAL RELAPSE OF A GERM-CELL TUMOR OF THE TESTIS, European journal of cancer, 31A(6), 1995, pp. 1023-1023
Risultati: 1-25 | 26-50 | 51-51